Moreover, the co-existence of EGFR gene mutations, ALK gene fusions, and ROS1 gene rearrangements has been reported in a few lung adenocarcinoma cases [25–27], but the co-alteration of ROS1, EGFR, and EML4-ALK in MPA remains unclear. The gene discussed is EGFR; the disease is lung adenocarcinoma.